Global Harmonization Efforts Must Go Further
IGBA Secretary General Discusses ICH Guidance And Streamlined Biosimilar Pathways
With global regulation of off-patent medicines continuing to evolve, IGBA secretary general Suzette Kox talks about the progress expected from regulatory harmonization for generics and a reduced clinical trial burden for biosimilars.